Navigation Links
GPS-like technology helps pinpoint best methods for moving injured players
Date:9/17/2007

The 15 minutes it took to remove Buffalo Bills player Kevin Everett off the field after he suffered a spinal cord injury may seem like a long time for someone needing acute medical care, but in fact, those minutes underscore how critical it is to carefully move a player with a suspected spinal cord injury off the field. It also highlights the challenges faced when needing to minimize any further movement to an injured spinal cord.

And those challenges have been the focus over the past eight years for Glenn Rechtine, M.D., professor of Orthopaedics at the University of Rochester Medical Center, and president of the American Spinal Injury Association. He and his colleagues believe they now know the best methods to move injured players off the field thanks to GPS-like technology.

Electromagnetic tracking devices, which work similar to GPS technology, can measure movement down to fractions of a millimeter, about the width of a piece of construction paper. By placing three to five of these tiny devices on the upper body of a cadaver, researchers were able to precisely measure how much an injured cervical spine moves at several important points in the process of removing a player from the field including taking off a helmet, putting on a cervical collar, and placing a player on the backboard for transportation to the ambulance.

The data was then analyzed to pinpoint which removal method produced the least amount of cervical spine movement, including the necks rotation, flexion and lateral bending. The teams findings have been published in several journals, such as Spine, the Journal of Trauma and the Journal of Neurosurgery Spine. In the near future, a manuscript will appear in the Journal of Athletic Training showing that a modified Lift and Slide method appears to produce the least amount of movement to an injured cervical spine.

While we strive to obtain zero movement, as that is what is best to help prevent further in
'/>"/>

Contact: Germaine Reinhardt
germaine_reinhardt@urmc.rochester.edu
585-275-6517
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Vedic vibration technology- the new cure for arthritis
2. Biotechnology industry expected to grow into a three billion dollar industry by 2002
3. Biotechnology on the lead
4. New Technology In MRI Scan Help Test Brain Cancer Therapy
5. New technology to decipher neural connections dealing with heredity and environment
6. Emergence Of New Gene Scanning Technology In Disease Research
7. CoQ10 bioavailability increased by Nanotechnology
8. Developing a new vaccine using a new technology
9. Scientists Develop New Technology To Find About Human Ancestors’ Teet
10. T-waves to sweep over imaging technology
11. Nanotechnology Revolution To Be Spearheaded By European Union

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...s embracing the latest tools of virtual communicat...ue with patients. Through Facebook, Twitter, and o...formation about his Atlanta plastic surgery prac...ts may have. , Atlanta, G...in Atlanta is taking full advantage of new online...
(Date:11/24/2009)...ser Clinic, located in San Diego, is helping the f... new modeling career. The race to remove his chest...n the middle of 2010 is on. , ...aser Clinic, located in San Diego, is helping the ...s new modeling career. The race to remove his ches...
(Date:11/23/2009)... team of researchers at the University of Californ...d a way to simulate blood flow on the computer to ...w tool that may help surgeons plan for a life-savi... performed on babies born with severe congenital h...eir work next week at the 62nd Annual Meeting of t...
(Date:11/23/2009)...upusFoundationofAmericaGreaterWashingtonChapter(LF...to-dayeducation,adviceandresourcesforthe75,000+peo...FAGW,s35thAnniversaryLuncheonwillbeheldonSat.,Dece...ettsAve.,N.E.,Washington( map ).Dress:Businessatti...oropportunitiesare$1,500including10seats,tableandp...
(Date:11/23/2009)...CMG)EncouragesFamiliestoGatherFamilyHealthHistoryI...009 ,, BETHESDA,Md.,Nov.23/PRNewswire-USNewswi...yHistoryDay,asdeclaredbytheU.S.SurgeonGeneral.TheA...ryonetoknowtheirfamilymedicalhistoryandiftheyhaven...tion,to"starttheconversation"aboutfamilymedicalhis...
Breaking Medicine News(10 mins):Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 2Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 3Health News:Tattoo Removal on the Fastest U.S. Marine 2Health News:New tool for helping pediatric heart surgery 2Health News:Washington Lupus Chapter Celebrates 35th Anniversary on December 5 2Health News:'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series 2
... drugs approved for use as second line therapy for...g results as frontline therapy for newly diagnosed...ed by scientists at The University of Texas M. D. ...enetic response - absence of the aberrant chromoso...
...on Health & Science University Cancer Institute re...of chronic myeloid leukemia (CML). , We are looki...here the cancer is coming from. We have discovere...t of the CML clone, said Thomas Bumm, M.D., OHSU C...
...oing to the doctor or overindulge in unhealthy hab...hDay News) -- The holiday season is also the seaso...hurchwell, associate director of the Vanderbilt He...ion deaths occurring between 1973 and 2001 reveals...
...December 8, 2007 -- Results from two investigation...nation with bortezomib provide preliminary anti-tu...actory multiple myeloma. Data from one study show... second study, sponsored by the United States Nati...
... Data that shed new light on,the treatment of resi...al,hip replacement, chronic immune thrombocytopeni...stmenopausal hormone replacement therapy will,be p..., December 8, from 10:00 to 11:00 a.m., "Complica...
...L, December 8, 2007 A series of studies presented...acology (ACNP) annual meeting elucidates evidence ... and cancer, providing a surprising possible scien... , Researchers at the National Institute for Me...
Other Medicine News:Health News:Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia 2Health News:Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia 3Health News:OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia 2Health News:Heart Attacks Peak During the Holidays 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 3Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 2Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 3Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 4Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 5Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 6Health News:Studies elucidate genetic links between cancer and schizophrenia 2
(Date:11/23/2009)...onewtherapiesforNon-Hodgkin,sLymphomas(NHL),theNCC...b(Azerra(TM),GlaxoSmithKline)asatherapyoptionforpa...psin(Istodax(R),GloucesterPharmaceuticals)asasugge...a(CTCL). ,, FORTWASHINGTON,Pa.,Nov.23/PRNewswir...eNationalComprehensiveCancerNetwork( NCCN )toupdat...
(Date:11/23/2009)...Reportlinker.comannouncesthatanewmarketresearchrep...Systems&Equipment-AGlobalMarketPerspective ,...zation-Systems--Equipment---A-Global-Market-Perspe...&utm_campaign=prnewswire ,, Steamsteril...rocedure.Steamsterilizationmarketisstableduetoregu...
(Date:11/23/2009)...Reportlinker.comannouncesthatanewmarketresearchrep...enDisposables-AWorldwideMarketReview ,, http...Disposables---A-Worldwide-Market-Review.html#utm_s...n=prnewswire ,, Withincreaseinrangeofinfect...eandhospitalfacilities,nonwovenshasemergedasagoldm...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 1BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 2BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 3BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 4BioCryst Awarded Additional 2477 2 Million by the U S Department of Health 26 Human Services To Develop Peramivir for Influenza 57736 5Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies 14167 1Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies 14167 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 1Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 3Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 4Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 5Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 7Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 8
...Med, the Hutchison Whampoa backed pharmaceutical a...lts for its Phase II,proof-of-concept study for HM...orm of inflammatory bowel disease. The trial met,...and showed an,equivalent drop in clinical symptom ...ent first-line standard of care in,mild-to-moderat...
...- Ceragenix Pharmaceuticals,Inc. (OTCBB:CGXP), a ...sease and dermatology, today announced that,resear... Paul,Janmey and Dr. Robert Bucki, in collaboratio...ity, have demonstrated in a series,of in vitro exp...wn,as CSA-13 shows promise as a potential therapy ...
Other Medicine Technology:Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 2Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 3Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 4Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 5Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 6Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 7Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis 8Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 2Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 3Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 4
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: